middle.news
Proteomics International Secures Chinese Patent for OxiDx, Extending Protection to 2039
2:28am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Proteomics International Secures Chinese Patent for OxiDx, Extending Protection to 2039
2:28am on Monday 2nd of June, 2025 AEST
Key Points
Chinese patent granted for OxiDx technology valid until 2039
Patent complements existing protections in USA, Japan, Europe, and Australia
OxiDx measures oxidative stress via a simple fingerprick blood test
Technology targets muscle injury detection in high-performance sports and horse racing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE